The use of the global activity limitation Indicator and healthy life years by member states and the European Commission.

被引:35
作者
Bogaert, Petronille [1 ,2 ]
Van Oyen, Herman [1 ,3 ]
Beluche, Isabelle [5 ]
Cambois, Emmanuelle [4 ]
Robine, Jean-Marie [5 ,6 ]
机构
[1] Sciensano, Epidemiol & Publ Hlth, Dept Publ Hlth & Surveillance, Rue Juliette Wytsmanstr 14, B-1050 Brussels, Belgium
[2] Tilburg Univ, Tilburg, Netherlands
[3] Univ Ghent, Ghent, Belgium
[4] French Inst Demog Studies INED, Paris, France
[5] INSERM, French Inst Hlth & Med Res, Paris, France
[6] Ecole Prat Hautes Etud, Paris, France
关键词
Global activity limitation Indicator; Disability-free life expectancy; Healthy life years; Disability; Policy; PROJECT; TARGET;
D O I
10.1186/s13690-018-0279-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: In 2005, the European Union (EU) started to use a disability-free life expectancy, known as Healthy Life Years (HLY), to monitor progress in the strategic European policies such as the 2000 Lisbon strategy. HLY are based on the underlying measure: the Global Activity Limitation Indicator (GALI). Twelve years after its implementation, this study aims to assess its current use in EU Member States and the European Commission. Methods: In March 2017, a questionnaire was sent to 28 Member states and the European Commission. The questionnaire inquired how the GALI and HLY are used to set policy targets, in which surveys the GALI has been introduced since 2005, how the GALI and HLY are presented, and what the capacity in each country is to investigate the GALI and HLY. Results: The survey was answered by 22 Member States and by the Commission. HLY are often used to set targets and develop strategies in health such as national health plans. Analysis of HLY has even led to policy change. In some countries, HLY have become the main indicator for health, gaining more importance than life expectancy. More recently, the GALI and HLY have also been used for policy targets outside the health sector such as in the area of pension and retirement age or in the context of sustainable development. Regarding surveys, the GALI is mostly obtained from the EU-SILC, SHARE and EHIS, but is also increasingly introduced in national surveys. National health reporting systems usually present HLY on their national statistics websites. Most countries have up to three specialists working on the GALI and HLY, which has been consistent through time. Others have increased their capacity over various institutions. Conclusion: HLY is an indicator that is systematically used to monitor health developments in most EU countries. The SHARE, EU-SILC and EHIS are commonly used to assess HLY through the GALI. The results are then described in reports and presented on national statistics websites and used in different policy settings. Expertise to analyse the GALI and HLY is available in most countries.
引用
收藏
页数:7
相关论文
共 12 条
  • [1] [Anonymous], 2016, SUST DEV EUR UN STAT
  • [2] Assessing the validity of the Global Activity Limitation Indicator in fourteen European countries
    Berger, Nicolas
    Van Oyen, Herman
    Cambois, Emmanuelle
    Fouweather, Tony
    Jagger, Carol
    Nusselder, Wilma
    Robine, Jean-Marie
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2015, 15
  • [3] Impact of Question Wording on the Measurement of Activity Limitation: Evidence From a Randomized Test in France
    Cambois, Emmanuelle
    Grobon, Sebastien
    Van Oyen, Herman
    Robine, Jean-Marie
    [J]. JOURNAL OF AGING AND HEALTH, 2016, 28 (07) : 1315 - 1338
  • [4] European Commission, 2012, TAK FORW STRAT IMPL
  • [5] European Commission, 2017, PROGR REP IMPL EUR D
  • [6] Mind the gap-reaching the European target of a 2-year increase in healthy life years in the next decade
    Jagger, Carol
    McKee, Martin
    Christensen, Kaare
    Lagiewka, Karolina
    Nusselder, Wilma
    Van Oyen, Herman
    Cambois, Emmanuelle
    Jeune, Bernard
    Robine, Jean-Marie
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2013, 23 (05) : 829 - 833
  • [7] The Global Activity Limitation Index measured function and disability similarly across European countries
    Jagger, Carol
    Gillies, Clare
    Cambois, Emmanuelle
    Van Oyen, Herman
    Nusselder, Wilma
    Robine, Jean-Marie
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (08) : 892 - 899
  • [8] Lagiewka K, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-23
  • [9] Measuring health and disability: supporting policy development. The European MHADIE project
    Leonardi, Matilde
    [J]. DISABILITY AND REHABILITATION, 2010, 32 : S1 - S8
  • [10] Oortwijn W., 2006, Evaluating the Uptake of the Healthy Life Years Indicator Final report